Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 15, 2006 (Vol. 26, No. 12)

Enabling Technologies at MipTec 2006

Drug Discovery Based on Microfluidics, GPCR and Kinase Targets, and Cell-based Assays

  • With only 20 new drugs approved by the FDA in 2005, down from 36 in the previous year, there is still a serious gap between R&D and productivity in the pharmaceutical industry. Opening "MipTec", recently held in Basel, Gianni Gromo, M.D., Ph.D., head of discovery research at Roche (www.roche.com), ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.